Fortress Biotech, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Fortress Biotech, Inc. (FBIO) had Lessee, Operating Lease, Liability, to be Paid, Year One of $3.13 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-13
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $3.13M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $3.13M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.99M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $2.94M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $3.13M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $3.13M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $2.99M 10-K · filed 2026-03-31 |
| 2025-09-30 | $2.94M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.94M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $2.94M 10-Q · filed 2025-05-15 |
| 2024-09-30 | $3.54M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $3.54M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $3.80M 10-Q · filed 2024-05-15 |
| 2023-09-30 | $3.80M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $3.77M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $3.67M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $3.55M 10-K · filed 2023-03-31 |
| 2022-09-30 | $3.27M 10-Q · filed 2022-11-14 |
| 2021-12-31 | $3.50M 10-K · filed 2022-03-28 |
| 2020-12-31 | $3.35M 10-K/A · filed 2021-04-09 |
| 2020-09-30 | $3.11M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $3.11M 10-Q · filed 2020-08-10 |
| 2019-12-31 | $2.97M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |